Achieving Cures Together focuses on advancing microbiome research, particularly in the development of Fecal Microbiota Transplantation therapies. With a partnership with the University of Minnesota, ACT aims to restore gut health and treat diseases such as Clostridium difficile infections, Crohn’s Disease, Autism, and more. Their objective is to save lives by promoting effective treatments and supporting groundbreaking research.
2015
47-5158356
$84.28 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Our fall fundraiser at the Winery at Sovereign Estates on September 12th.
Participate in the Twin Cities Marathon to support our cause.
Read firsthand accounts from patients whose lives were changed through our treatments.
Developed Revolutionary Product
ACT supported the development of a revolutionary encapsulated microbial restoration product.
Supported 25 Clinical Trials
ACT has supported 25 clinical trials utilizing microbial restoration to target 13 illnesses.
Alleviated Human Suffering
Supported microbial restoration treatment for over 2,000 patients suffering from recurrent Clostridioides difficile.
2023-09-12
The annual Growing Hope fundraiser that raises funds for microbiome research.
2023-10-06
Community members participated in the Twin Cities Marathon to support ACT.
2023-05-18
A fundraising run organized to promote awareness for Clostridium difficile infections.
2024-10-06
Join our team and help raise funds for microbiome research.
Learn More2024-05-18
A marathon event to promote awareness and raise funds for ACT.
Learn More"Dr. Khoruts shared, ‘if only we would have seen him a week sooner’. If only someone would have told us."
Kathy Wise
Family Member of Patient
"After the fecal microbial transplant, I improved! I could sleep again."
Molly M
Cancer Survivor
"Without microbiota transplants, I would not have survived."
Tim Wise
Patient
Overall Score
45
24
/100
Program Expense Ratio
81.62%
14
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
0.1992
4
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 483.7K | 110.53% |
Program Services | 0 | 0.00% |
Investment Income | 0 | 0.00% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 437.6K | 100.00% |